Literature DB >> 31731987

Diagnostic Tests for Latent Tuberculosis Infection.

Michelle K Haas1, Robert W Belknap2.   

Abstract

Diagnosing latent tuberculosis (TB) infection (LTBI) is important globally for TB prevention. LTBI diagnosis requires a positive test for infection and negative evaluation for active disease. Current tests measure an immunologic response and include the tuberculin skin test (TST) and interferon-gamma release assays (IGRAs), T-SPOT.TB and QuantiFERON. The IGRAs are preferred in bacille Calmette-Guérin-vaccinated populations. The TST is still used when cost or logistical advantages over the IGRAs exist. Both TST and IGRAs have low positive predictive values. Tests that differentiate the TB spectrum and better predict future TB risk are needed.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Interferon-gamma release assay; LTBI; Latent tuberculosis infection; QuantiFERON; T-SPOT.TB; TST; Tuberculin skin test

Year:  2019        PMID: 31731987     DOI: 10.1016/j.ccm.2019.07.007

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  8 in total

Review 1.  Interferon-gamma release assays in tuberculous uveitis: a comprehensive review.

Authors:  Usanee Tungsattayathitthan; Sutasinee Boonsopon; Nattaporn Tesavibul; Tararaj Dharakul; Pitipol Choopong
Journal:  Int J Ophthalmol       Date:  2022-09-18       Impact factor: 1.645

Review 2.  Of tuberculosis and non-tuberculous mycobacterial infections - a comparative analysis of epidemiology, diagnosis and treatment.

Authors:  Radha Gopalaswamy; Sivakumar Shanmugam; Rajesh Mondal; Selvakumar Subbian
Journal:  J Biomed Sci       Date:  2020-06-17       Impact factor: 8.410

Review 3.  Latent tuberculosis infection: recent progress and challenges in South Korea.

Authors:  Doosoo Jeon
Journal:  Korean J Intern Med       Date:  2020-02-28       Impact factor: 2.884

Review 4.  Addressing Latent Tuberculosis: New Advances in Mimicking the Disease, Discovering Key Targets, and Designing Hit Compounds.

Authors:  André Campaniço; Shrika G Harjivan; Digby F Warner; Rui Moreira; Francisca Lopes
Journal:  Int J Mol Sci       Date:  2020-11-23       Impact factor: 5.923

5.  Low-Density Granulocytes Affect T-SPOT.TB Assay by Inhibiting the Production of Interferon-γ in T Cells via PD-L1/PD-1 Pathway.

Authors:  Jiayue Rao; Rigu Su; Yiping Peng; Yang Guo; Zikun Huang; Yutao Ye; Yujie Gao; Jun Liu; Lu Zhang; Qing Luo; Junming Li
Journal:  Front Microbiol       Date:  2021-01-28       Impact factor: 5.640

Review 6.  Tuberculous Granuloma: Emerging Insights From Proteomics and Metabolomics.

Authors:  Abisola Regina Sholeye; Aurelia A Williams; Du Toit Loots; A Marceline Tutu van Furth; Martijn van der Kuip; Shayne Mason
Journal:  Front Neurol       Date:  2022-03-21       Impact factor: 4.003

7.  Subclinical Tuberculosis Disease-A Review and Analysis of Prevalence Surveys to Inform Definitions, Burden, Associations, and Screening Methodology.

Authors:  Beatrice Frascella; Alexandra S Richards; Bianca Sossen; Jon C Emery; Anna Odone; Irwin Law; Ikushi Onozaki; Hanif Esmail; Rein M G J Houben
Journal:  Clin Infect Dis       Date:  2021-08-02       Impact factor: 9.079

8.  Value of gamma interferon enzyme-linked immunospot assay in the diagnosis of peritoneal dialysis-associated tuberculous peritonitis.

Authors:  Qiuxia Fan; Xiaoyan Huang; Jieyun Zhang; Yinan Sun; Zuying Xiong; Zibo Xiong
Journal:  Int Urol Nephrol       Date:  2021-07-14       Impact factor: 2.370

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.